Literature DB >> 8481950

Localization of neuropeptide Y and atrial natriuretic peptide in the endothelial cells of human umbilical blood vessels.

W Q Cai1, P Bodin, A Sexton, A Loesch, G Burnstock.   

Abstract

The localization of neuropeptide Y (NPY) and atrial natriuretic peptide (ANP) in the endothelial cells of human umbilical blood vessels was studied using the pre-embedding peroxidase-antiperoxidase (PAP) technique for electron microscopy and avidin-biotin-complex (ABC) immunostaining for endothelial cells cultured from umbilical vein. Subpopulations of NPY- and ANP-immunoreactive endothelial cells were present in term umbilical vein and artery. The umbilical vein contained more positive cells than the artery. The percentage of NPY- and ANP-immunoreactive umbilical vein cells in culture was 32% and 44%, respectively, out of a total of 3013 cells examined. The possibility that these potent vasoactive substances located in the endothelial cells of the non-innervated umbilical vessels are involved in the local regulation of blood flow is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481950     DOI: 10.1007/bf00323584

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  30 in total

1.  Localization of arginine-vasopressin in endothelial cells of rat pulmonary artery.

Authors:  A Loesch; A Tomlinson; G Burnstock
Journal:  Anat Embryol (Berl)       Date:  1991

2.  Neuropeptide Y modulates adrenergic neurotransmission by an endothelium dependent mechanism.

Authors:  R N Daly; J P Hieble
Journal:  Eur J Pharmacol       Date:  1987-06-26       Impact factor: 4.432

3.  Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs.

Authors:  K L Goetz; B C Wang; J B Madwed; J L Zhu; R J Leadley
Journal:  Am J Physiol       Date:  1988-12

4.  Characterization, localization and actions of endothelins in umbilical vessels and placenta of man.

Authors:  A Hemsén; C Gillis; O Larsson; A Haegerstrand; J M Lundberg
Journal:  Acta Physiol Scand       Date:  1991-12

5.  Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia.

Authors:  P Milner; V Ralevic; A M Hopwood; E Fehér; J Lincoln; K A Kirkpatrick; G Burnstock
Journal:  Experientia       Date:  1989-02-15

6.  A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor.

Authors:  M Chinkers; D L Garbers; M S Chang; D G Lowe; H M Chin; D V Goeddel; S Schulz
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

7.  Heterogeneous binding sites for alpha-atrial natriuretic peptide in human umbilical cord and placenta.

Authors:  S P Salas; R F Power; A Singleton; J Wharton; J M Polak; J Brown
Journal:  Am J Physiol       Date:  1991-09

8.  Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.

Authors:  R J Winquist; E P Faison; S A Waldman; K Schwartz; F Murad; R M Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  Release of endothelium-derived relaxing factor from human umbilical vessels.

Authors:  J Van de Voorde; H Vanderstichele; I Leusen
Journal:  Circ Res       Date:  1987-04       Impact factor: 17.367

10.  Co-release of neuropeptide Y (NPY)-like immunoreactivity and catecholamines in newborn infants.

Authors:  J M Lundberg; A Hemsén; G Fried; E Theodorsson-Norheim; H Lagercrantz
Journal:  Acta Physiol Scand       Date:  1986-03
View more
  2 in total

1.  A study of the ultrastructure of developing human umbilical vessels.

Authors:  A J Sexton; M Turmaine; W Q Cai; G Burnstock
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

2.  Colocalization of vasoactive substances in the endothelial cells of human umbilical vessels.

Authors:  W Q Cai; K Dikranian; P Bodin; M Turmaine; G Burnstock
Journal:  Cell Tissue Res       Date:  1993-12       Impact factor: 5.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.